nodes	percent_of_prediction	percent_of_DWPC	metapath
Pirbuterol—Clenbuterol—TNF—urinary bladder cancer	0.0178	0.704	CrCbGaD
Pirbuterol—Shock—Mitomycin—urinary bladder cancer	0.00853	0.00875	CcSEcCtD
Pirbuterol—Dizziness—Valrubicin—urinary bladder cancer	0.00832	0.00854	CcSEcCtD
Pirbuterol—Anorexia—Mitomycin—urinary bladder cancer	0.00826	0.00848	CcSEcCtD
Pirbuterol—Vomiting—Valrubicin—urinary bladder cancer	0.008	0.00821	CcSEcCtD
Pirbuterol—Rash—Valrubicin—urinary bladder cancer	0.00793	0.00814	CcSEcCtD
Pirbuterol—Dermatitis—Valrubicin—urinary bladder cancer	0.00793	0.00813	CcSEcCtD
Pirbuterol—Headache—Valrubicin—urinary bladder cancer	0.00788	0.00809	CcSEcCtD
Pirbuterol—Somnolence—Mitomycin—urinary bladder cancer	0.00771	0.00791	CcSEcCtD
Pirbuterol—Nasal congestion—Cisplatin—urinary bladder cancer	0.00763	0.00783	CcSEcCtD
Pirbuterol—Decreased appetite—Mitomycin—urinary bladder cancer	0.00754	0.00773	CcSEcCtD
Pirbuterol—Nausea—Valrubicin—urinary bladder cancer	0.00747	0.00767	CcSEcCtD
Pirbuterol—Fatigue—Mitomycin—urinary bladder cancer	0.00747	0.00767	CcSEcCtD
Pirbuterol—Epinephrine—TNF—urinary bladder cancer	0.00747	0.296	CrCbGaD
Pirbuterol—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00714	0.00733	CcSEcCtD
Pirbuterol—Weight increased—Thiotepa—urinary bladder cancer	0.00698	0.00716	CcSEcCtD
Pirbuterol—Stomatitis—Thiotepa—urinary bladder cancer	0.00666	0.00684	CcSEcCtD
Pirbuterol—Cramp muscle—Cisplatin—urinary bladder cancer	0.00626	0.00642	CcSEcCtD
Pirbuterol—Asthenia—Mitomycin—urinary bladder cancer	0.00622	0.00638	CcSEcCtD
Pirbuterol—Dysphonia—Epirubicin—urinary bladder cancer	0.00598	0.00614	CcSEcCtD
Pirbuterol—Diarrhoea—Mitomycin—urinary bladder cancer	0.00593	0.00608	CcSEcCtD
Pirbuterol—Cramp muscle—Etoposide—urinary bladder cancer	0.00574	0.00589	CcSEcCtD
Pirbuterol—Dizziness—Mitomycin—urinary bladder cancer	0.00573	0.00588	CcSEcCtD
Pirbuterol—Glossitis—Methotrexate—urinary bladder cancer	0.0057	0.00585	CcSEcCtD
Pirbuterol—Stomatitis—Gemcitabine—urinary bladder cancer	0.0056	0.00575	CcSEcCtD
Pirbuterol—Dysphonia—Doxorubicin—urinary bladder cancer	0.00553	0.00568	CcSEcCtD
Pirbuterol—Vomiting—Mitomycin—urinary bladder cancer	0.00551	0.00565	CcSEcCtD
Pirbuterol—Stomatitis—Fluorouracil—urinary bladder cancer	0.00551	0.00565	CcSEcCtD
Pirbuterol—Rash—Mitomycin—urinary bladder cancer	0.00547	0.00561	CcSEcCtD
Pirbuterol—Dermatitis—Mitomycin—urinary bladder cancer	0.00546	0.0056	CcSEcCtD
Pirbuterol—Headache—Mitomycin—urinary bladder cancer	0.00543	0.00557	CcSEcCtD
Pirbuterol—Alopecia—Thiotepa—urinary bladder cancer	0.00542	0.00556	CcSEcCtD
Pirbuterol—Glossitis—Epirubicin—urinary bladder cancer	0.00534	0.00548	CcSEcCtD
Pirbuterol—Tension—Thiotepa—urinary bladder cancer	0.00524	0.00538	CcSEcCtD
Pirbuterol—Stomatitis—Cisplatin—urinary bladder cancer	0.00522	0.00536	CcSEcCtD
Pirbuterol—Nervousness—Thiotepa—urinary bladder cancer	0.00519	0.00532	CcSEcCtD
Pirbuterol—Back pain—Thiotepa—urinary bladder cancer	0.00517	0.0053	CcSEcCtD
Pirbuterol—Nausea—Mitomycin—urinary bladder cancer	0.00515	0.00528	CcSEcCtD
Pirbuterol—Hypoaesthesia—Fluorouracil—urinary bladder cancer	0.00505	0.00518	CcSEcCtD
Pirbuterol—Glossitis—Doxorubicin—urinary bladder cancer	0.00494	0.00507	CcSEcCtD
Pirbuterol—Agitation—Thiotepa—urinary bladder cancer	0.00491	0.00504	CcSEcCtD
Pirbuterol—Stomatitis—Etoposide—urinary bladder cancer	0.00479	0.00491	CcSEcCtD
Pirbuterol—Cough—Thiotepa—urinary bladder cancer	0.00466	0.00478	CcSEcCtD
Pirbuterol—Alopecia—Gemcitabine—urinary bladder cancer	0.00456	0.00468	CcSEcCtD
Pirbuterol—Anxiety—Thiotepa—urinary bladder cancer	0.00453	0.00465	CcSEcCtD
Pirbuterol—Alopecia—Fluorouracil—urinary bladder cancer	0.00448	0.0046	CcSEcCtD
Pirbuterol—Flushing—Cisplatin—urinary bladder cancer	0.00447	0.00458	CcSEcCtD
Pirbuterol—Confusional state—Thiotepa—urinary bladder cancer	0.0044	0.00451	CcSEcCtD
Pirbuterol—Hypoaesthesia—Etoposide—urinary bladder cancer	0.00439	0.0045	CcSEcCtD
Pirbuterol—Back pain—Gemcitabine—urinary bladder cancer	0.00435	0.00446	CcSEcCtD
Pirbuterol—Tachycardia—Thiotepa—urinary bladder cancer	0.00425	0.00436	CcSEcCtD
Pirbuterol—Alopecia—Cisplatin—urinary bladder cancer	0.00425	0.00436	CcSEcCtD
Pirbuterol—Anorexia—Thiotepa—urinary bladder cancer	0.00416	0.00426	CcSEcCtD
Pirbuterol—Flushing—Etoposide—urinary bladder cancer	0.00409	0.0042	CcSEcCtD
Pirbuterol—Muscle spasms—Cisplatin—urinary bladder cancer	0.00403	0.00413	CcSEcCtD
Pirbuterol—Tremor—Cisplatin—urinary bladder cancer	0.00392	0.00403	CcSEcCtD
Pirbuterol—Cough—Gemcitabine—urinary bladder cancer	0.00392	0.00402	CcSEcCtD
Pirbuterol—Alopecia—Etoposide—urinary bladder cancer	0.00389	0.004	CcSEcCtD
Pirbuterol—Somnolence—Thiotepa—urinary bladder cancer	0.00388	0.00398	CcSEcCtD
Pirbuterol—Chest pain—Gemcitabine—urinary bladder cancer	0.00383	0.00392	CcSEcCtD
Pirbuterol—Decreased appetite—Thiotepa—urinary bladder cancer	0.00379	0.00389	CcSEcCtD
Pirbuterol—Chest pain—Fluorouracil—urinary bladder cancer	0.00376	0.00386	CcSEcCtD
Pirbuterol—Fatigue—Thiotepa—urinary bladder cancer	0.00376	0.00386	CcSEcCtD
Pirbuterol—Back pain—Etoposide—urinary bladder cancer	0.00371	0.00381	CcSEcCtD
Pirbuterol—Muscle spasms—Etoposide—urinary bladder cancer	0.00369	0.00378	CcSEcCtD
Pirbuterol—Oedema—Gemcitabine—urinary bladder cancer	0.00367	0.00376	CcSEcCtD
Pirbuterol—Confusional state—Fluorouracil—urinary bladder cancer	0.00364	0.00373	CcSEcCtD
Pirbuterol—Oedema—Fluorouracil—urinary bladder cancer	0.00361	0.0037	CcSEcCtD
Pirbuterol—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00359	0.00369	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00356	0.00366	CcSEcCtD
Pirbuterol—Anxiety—Cisplatin—urinary bladder cancer	0.00355	0.00365	CcSEcCtD
Pirbuterol—Tachycardia—Fluorouracil—urinary bladder cancer	0.00352	0.00361	CcSEcCtD
Pirbuterol—Migraine—Epirubicin—urinary bladder cancer	0.00352	0.00361	CcSEcCtD
Pirbuterol—Anorexia—Gemcitabine—urinary bladder cancer	0.0035	0.00359	CcSEcCtD
Pirbuterol—Abdominal pain—Thiotepa—urinary bladder cancer	0.00345	0.00354	CcSEcCtD
Pirbuterol—Anorexia—Fluorouracil—urinary bladder cancer	0.00344	0.00353	CcSEcCtD
Pirbuterol—Hypotension—Gemcitabine—urinary bladder cancer	0.00343	0.00352	CcSEcCtD
Pirbuterol—Oedema—Cisplatin—urinary bladder cancer	0.00342	0.00351	CcSEcCtD
Pirbuterol—Loss of consciousness—Etoposide—urinary bladder cancer	0.00337	0.00346	CcSEcCtD
Pirbuterol—Hypotension—Fluorouracil—urinary bladder cancer	0.00337	0.00346	CcSEcCtD
Pirbuterol—Cough—Etoposide—urinary bladder cancer	0.00335	0.00343	CcSEcCtD
Pirbuterol—Tachycardia—Cisplatin—urinary bladder cancer	0.00334	0.00342	CcSEcCtD
Pirbuterol—Insomnia—Gemcitabine—urinary bladder cancer	0.00332	0.0034	CcSEcCtD
Pirbuterol—Chest pain—Etoposide—urinary bladder cancer	0.00327	0.00335	CcSEcCtD
Pirbuterol—Insomnia—Fluorouracil—urinary bladder cancer	0.00326	0.00335	CcSEcCtD
Pirbuterol—Somnolence—Gemcitabine—urinary bladder cancer	0.00326	0.00334	CcSEcCtD
Pirbuterol—Anorexia—Cisplatin—urinary bladder cancer	0.00326	0.00334	CcSEcCtD
Pirbuterol—Migraine—Doxorubicin—urinary bladder cancer	0.00325	0.00334	CcSEcCtD
Pirbuterol—Somnolence—Fluorouracil—urinary bladder cancer	0.00321	0.00329	CcSEcCtD
Pirbuterol—Hypotension—Cisplatin—urinary bladder cancer	0.00319	0.00328	CcSEcCtD
Pirbuterol—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00319	0.00327	CcSEcCtD
Pirbuterol—Fatigue—Gemcitabine—urinary bladder cancer	0.00316	0.00324	CcSEcCtD
Pirbuterol—Confusional state—Etoposide—urinary bladder cancer	0.00316	0.00324	CcSEcCtD
Pirbuterol—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00313	0.00322	CcSEcCtD
Pirbuterol—Asthenia—Thiotepa—urinary bladder cancer	0.00313	0.00321	CcSEcCtD
Pirbuterol—Pruritus—Thiotepa—urinary bladder cancer	0.00308	0.00316	CcSEcCtD
Pirbuterol—Tachycardia—Etoposide—urinary bladder cancer	0.00306	0.00314	CcSEcCtD
Pirbuterol—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00302	0.0031	CcSEcCtD
Pirbuterol—Anorexia—Etoposide—urinary bladder cancer	0.00299	0.00306	CcSEcCtD
Pirbuterol—Diarrhoea—Thiotepa—urinary bladder cancer	0.00298	0.00306	CcSEcCtD
Pirbuterol—Decreased appetite—Cisplatin—urinary bladder cancer	0.00297	0.00305	CcSEcCtD
Pirbuterol—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00297	0.00305	CcSEcCtD
Pirbuterol—Drowsiness—Methotrexate—urinary bladder cancer	0.00294	0.00302	CcSEcCtD
Pirbuterol—Hypotension—Etoposide—urinary bladder cancer	0.00293	0.003	CcSEcCtD
Pirbuterol—Dizziness—Thiotepa—urinary bladder cancer	0.00288	0.00296	CcSEcCtD
Pirbuterol—Stomatitis—Methotrexate—urinary bladder cancer	0.00287	0.00294	CcSEcCtD
Pirbuterol—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00282	0.00289	CcSEcCtD
Pirbuterol—Weight increased—Epirubicin—urinary bladder cancer	0.00281	0.00288	CcSEcCtD
Pirbuterol—Somnolence—Etoposide—urinary bladder cancer	0.00278	0.00286	CcSEcCtD
Pirbuterol—Vomiting—Thiotepa—urinary bladder cancer	0.00277	0.00284	CcSEcCtD
Pirbuterol—Drowsiness—Epirubicin—urinary bladder cancer	0.00275	0.00282	CcSEcCtD
Pirbuterol—Rash—Thiotepa—urinary bladder cancer	0.00275	0.00282	CcSEcCtD
Pirbuterol—Dermatitis—Thiotepa—urinary bladder cancer	0.00275	0.00282	CcSEcCtD
Pirbuterol—Headache—Thiotepa—urinary bladder cancer	0.00273	0.0028	CcSEcCtD
Pirbuterol—Decreased appetite—Etoposide—urinary bladder cancer	0.00272	0.00279	CcSEcCtD
Pirbuterol—Fatigue—Etoposide—urinary bladder cancer	0.0027	0.00277	CcSEcCtD
Pirbuterol—Stomatitis—Epirubicin—urinary bladder cancer	0.00268	0.00275	CcSEcCtD
Pirbuterol—Asthenia—Gemcitabine—urinary bladder cancer	0.00263	0.0027	CcSEcCtD
Pirbuterol—Weight increased—Doxorubicin—urinary bladder cancer	0.0026	0.00267	CcSEcCtD
Pirbuterol—Pruritus—Gemcitabine—urinary bladder cancer	0.00259	0.00266	CcSEcCtD
Pirbuterol—Nausea—Thiotepa—urinary bladder cancer	0.00259	0.00266	CcSEcCtD
Pirbuterol—Feeling abnormal—Etoposide—urinary bladder cancer	0.00258	0.00265	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00256	0.00263	CcSEcCtD
Pirbuterol—Pruritus—Fluorouracil—urinary bladder cancer	0.00255	0.00262	CcSEcCtD
Pirbuterol—Drowsiness—Doxorubicin—urinary bladder cancer	0.00255	0.00261	CcSEcCtD
Pirbuterol—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00251	0.00257	CcSEcCtD
Pirbuterol—Stomatitis—Doxorubicin—urinary bladder cancer	0.00248	0.00255	CcSEcCtD
Pirbuterol—Abdominal pain—Etoposide—urinary bladder cancer	0.00248	0.00254	CcSEcCtD
Pirbuterol—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00247	0.00253	CcSEcCtD
Pirbuterol—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00246	0.00252	CcSEcCtD
Pirbuterol—Asthenia—Cisplatin—urinary bladder cancer	0.00245	0.00252	CcSEcCtD
Pirbuterol—Dizziness—Fluorouracil—urinary bladder cancer	0.00238	0.00245	CcSEcCtD
Pirbuterol—Diarrhoea—Cisplatin—urinary bladder cancer	0.00234	0.0024	CcSEcCtD
Pirbuterol—Alopecia—Methotrexate—urinary bladder cancer	0.00233	0.00239	CcSEcCtD
Pirbuterol—Vomiting—Gemcitabine—urinary bladder cancer	0.00233	0.00239	CcSEcCtD
Pirbuterol—Rash—Gemcitabine—urinary bladder cancer	0.00231	0.00237	CcSEcCtD
Pirbuterol—Dermatitis—Gemcitabine—urinary bladder cancer	0.00231	0.00237	CcSEcCtD
Pirbuterol—Headache—Gemcitabine—urinary bladder cancer	0.0023	0.00236	CcSEcCtD
Pirbuterol—Flushing—Epirubicin—urinary bladder cancer	0.00229	0.00235	CcSEcCtD
Pirbuterol—Vomiting—Fluorouracil—urinary bladder cancer	0.00229	0.00235	CcSEcCtD
Pirbuterol—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00227	0.00233	CcSEcCtD
Pirbuterol—Rash—Fluorouracil—urinary bladder cancer	0.00227	0.00233	CcSEcCtD
Pirbuterol—Dermatitis—Fluorouracil—urinary bladder cancer	0.00227	0.00233	CcSEcCtD
Pirbuterol—Headache—Fluorouracil—urinary bladder cancer	0.00226	0.00232	CcSEcCtD
Pirbuterol—Asthenia—Etoposide—urinary bladder cancer	0.00225	0.0023	CcSEcCtD
Pirbuterol—Back pain—Methotrexate—urinary bladder cancer	0.00222	0.00228	CcSEcCtD
Pirbuterol—Pruritus—Etoposide—urinary bladder cancer	0.00222	0.00227	CcSEcCtD
Pirbuterol—Alopecia—Epirubicin—urinary bladder cancer	0.00218	0.00224	CcSEcCtD
Pirbuterol—Nausea—Gemcitabine—urinary bladder cancer	0.00218	0.00223	CcSEcCtD
Pirbuterol—Vomiting—Cisplatin—urinary bladder cancer	0.00217	0.00223	CcSEcCtD
Pirbuterol—Rash—Cisplatin—urinary bladder cancer	0.00216	0.00221	CcSEcCtD
Pirbuterol—Dermatitis—Cisplatin—urinary bladder cancer	0.00215	0.00221	CcSEcCtD
Pirbuterol—Diarrhoea—Etoposide—urinary bladder cancer	0.00214	0.0022	CcSEcCtD
Pirbuterol—Nausea—Fluorouracil—urinary bladder cancer	0.00214	0.0022	CcSEcCtD
Pirbuterol—Flushing—Doxorubicin—urinary bladder cancer	0.00212	0.00218	CcSEcCtD
Pirbuterol—Tension—Epirubicin—urinary bladder cancer	0.00211	0.00217	CcSEcCtD
Pirbuterol—Nervousness—Epirubicin—urinary bladder cancer	0.00209	0.00214	CcSEcCtD
Pirbuterol—Back pain—Epirubicin—urinary bladder cancer	0.00208	0.00213	CcSEcCtD
Pirbuterol—Dizziness—Etoposide—urinary bladder cancer	0.00207	0.00212	CcSEcCtD
Pirbuterol—Muscle spasms—Epirubicin—urinary bladder cancer	0.00207	0.00212	CcSEcCtD
Pirbuterol—Nausea—Cisplatin—urinary bladder cancer	0.00203	0.00208	CcSEcCtD
Pirbuterol—Alopecia—Doxorubicin—urinary bladder cancer	0.00202	0.00207	CcSEcCtD
Pirbuterol—Cough—Methotrexate—urinary bladder cancer	0.00201	0.00206	CcSEcCtD
Pirbuterol—Vomiting—Etoposide—urinary bladder cancer	0.00199	0.00204	CcSEcCtD
Pirbuterol—Agitation—Epirubicin—urinary bladder cancer	0.00198	0.00203	CcSEcCtD
Pirbuterol—Rash—Etoposide—urinary bladder cancer	0.00197	0.00203	CcSEcCtD
Pirbuterol—Dermatitis—Etoposide—urinary bladder cancer	0.00197	0.00202	CcSEcCtD
Pirbuterol—Headache—Etoposide—urinary bladder cancer	0.00196	0.00201	CcSEcCtD
Pirbuterol—Chest pain—Methotrexate—urinary bladder cancer	0.00196	0.00201	CcSEcCtD
Pirbuterol—Tension—Doxorubicin—urinary bladder cancer	0.00195	0.002	CcSEcCtD
Pirbuterol—Nervousness—Doxorubicin—urinary bladder cancer	0.00193	0.00198	CcSEcCtD
Pirbuterol—Syncope—Epirubicin—urinary bladder cancer	0.00193	0.00198	CcSEcCtD
Pirbuterol—Back pain—Doxorubicin—urinary bladder cancer	0.00193	0.00197	CcSEcCtD
Pirbuterol—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00191	0.00196	CcSEcCtD
Pirbuterol—Palpitations—Epirubicin—urinary bladder cancer	0.0019	0.00195	CcSEcCtD
Pirbuterol—Confusional state—Methotrexate—urinary bladder cancer	0.00189	0.00194	CcSEcCtD
Pirbuterol—Loss of consciousness—Epirubicin—urinary bladder cancer	0.00189	0.00194	CcSEcCtD
Pirbuterol—Cough—Epirubicin—urinary bladder cancer	0.00188	0.00193	CcSEcCtD
Pirbuterol—Nausea—Etoposide—urinary bladder cancer	0.00186	0.00191	CcSEcCtD
Pirbuterol—Chest pain—Epirubicin—urinary bladder cancer	0.00183	0.00188	CcSEcCtD
Pirbuterol—Agitation—Doxorubicin—urinary bladder cancer	0.00183	0.00188	CcSEcCtD
Pirbuterol—Anxiety—Epirubicin—urinary bladder cancer	0.00182	0.00187	CcSEcCtD
Pirbuterol—Dry mouth—Epirubicin—urinary bladder cancer	0.00179	0.00184	CcSEcCtD
Pirbuterol—Anorexia—Methotrexate—urinary bladder cancer	0.00179	0.00183	CcSEcCtD
Pirbuterol—Syncope—Doxorubicin—urinary bladder cancer	0.00178	0.00183	CcSEcCtD
Pirbuterol—Confusional state—Epirubicin—urinary bladder cancer	0.00177	0.00182	CcSEcCtD
Pirbuterol—Palpitations—Doxorubicin—urinary bladder cancer	0.00176	0.0018	CcSEcCtD
Pirbuterol—Oedema—Epirubicin—urinary bladder cancer	0.00176	0.0018	CcSEcCtD
Pirbuterol—Hypotension—Methotrexate—urinary bladder cancer	0.00175	0.0018	CcSEcCtD
Pirbuterol—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00175	0.00179	CcSEcCtD
Pirbuterol—Cough—Doxorubicin—urinary bladder cancer	0.00174	0.00178	CcSEcCtD
Pirbuterol—Shock—Epirubicin—urinary bladder cancer	0.00173	0.00177	CcSEcCtD
Pirbuterol—Tachycardia—Epirubicin—urinary bladder cancer	0.00171	0.00176	CcSEcCtD
Pirbuterol—Insomnia—Methotrexate—urinary bladder cancer	0.0017	0.00174	CcSEcCtD
Pirbuterol—Chest pain—Doxorubicin—urinary bladder cancer	0.00169	0.00174	CcSEcCtD
Pirbuterol—Anxiety—Doxorubicin—urinary bladder cancer	0.00169	0.00173	CcSEcCtD
Pirbuterol—Anorexia—Epirubicin—urinary bladder cancer	0.00167	0.00172	CcSEcCtD
Pirbuterol—Somnolence—Methotrexate—urinary bladder cancer	0.00167	0.00171	CcSEcCtD
Pirbuterol—Dry mouth—Doxorubicin—urinary bladder cancer	0.00166	0.0017	CcSEcCtD
Pirbuterol—Hypotension—Epirubicin—urinary bladder cancer	0.00164	0.00168	CcSEcCtD
Pirbuterol—Confusional state—Doxorubicin—urinary bladder cancer	0.00164	0.00168	CcSEcCtD
Pirbuterol—Decreased appetite—Methotrexate—urinary bladder cancer	0.00163	0.00167	CcSEcCtD
Pirbuterol—Oedema—Doxorubicin—urinary bladder cancer	0.00162	0.00167	CcSEcCtD
Pirbuterol—Fatigue—Methotrexate—urinary bladder cancer	0.00162	0.00166	CcSEcCtD
Pirbuterol—Shock—Doxorubicin—urinary bladder cancer	0.0016	0.00164	CcSEcCtD
Pirbuterol—Insomnia—Epirubicin—urinary bladder cancer	0.00159	0.00163	CcSEcCtD
Pirbuterol—Tachycardia—Doxorubicin—urinary bladder cancer	0.00159	0.00163	CcSEcCtD
Pirbuterol—Somnolence—Epirubicin—urinary bladder cancer	0.00156	0.0016	CcSEcCtD
Pirbuterol—Anorexia—Doxorubicin—urinary bladder cancer	0.00155	0.00159	CcSEcCtD
Pirbuterol—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00155	0.00159	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00153	0.00157	CcSEcCtD
Pirbuterol—Decreased appetite—Epirubicin—urinary bladder cancer	0.00153	0.00157	CcSEcCtD
Pirbuterol—Hypotension—Doxorubicin—urinary bladder cancer	0.00152	0.00156	CcSEcCtD
Pirbuterol—Fatigue—Epirubicin—urinary bladder cancer	0.00151	0.00155	CcSEcCtD
Pirbuterol—Abdominal pain—Methotrexate—urinary bladder cancer	0.00148	0.00152	CcSEcCtD
Pirbuterol—Insomnia—Doxorubicin—urinary bladder cancer	0.00147	0.00151	CcSEcCtD
Pirbuterol—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00145	0.00148	CcSEcCtD
Pirbuterol—Somnolence—Doxorubicin—urinary bladder cancer	0.00144	0.00148	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00144	0.00147	CcSEcCtD
Pirbuterol—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00141	0.00145	CcSEcCtD
Pirbuterol—Fatigue—Doxorubicin—urinary bladder cancer	0.0014	0.00144	CcSEcCtD
Pirbuterol—Abdominal pain—Epirubicin—urinary bladder cancer	0.00139	0.00142	CcSEcCtD
Pirbuterol—Asthenia—Methotrexate—urinary bladder cancer	0.00135	0.00138	CcSEcCtD
Pirbuterol—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00134	0.00137	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00133	0.00136	CcSEcCtD
Pirbuterol—Pruritus—Methotrexate—urinary bladder cancer	0.00133	0.00136	CcSEcCtD
Pirbuterol—Abdominal pain—Doxorubicin—urinary bladder cancer	0.00128	0.00132	CcSEcCtD
Pirbuterol—Diarrhoea—Methotrexate—urinary bladder cancer	0.00128	0.00132	CcSEcCtD
Pirbuterol—Asthenia—Epirubicin—urinary bladder cancer	0.00126	0.00129	CcSEcCtD
Pirbuterol—Pruritus—Epirubicin—urinary bladder cancer	0.00124	0.00127	CcSEcCtD
Pirbuterol—Dizziness—Methotrexate—urinary bladder cancer	0.00124	0.00127	CcSEcCtD
Pirbuterol—Diarrhoea—Epirubicin—urinary bladder cancer	0.0012	0.00123	CcSEcCtD
Pirbuterol—Vomiting—Methotrexate—urinary bladder cancer	0.00119	0.00122	CcSEcCtD
Pirbuterol—Rash—Methotrexate—urinary bladder cancer	0.00118	0.00121	CcSEcCtD
Pirbuterol—Dermatitis—Methotrexate—urinary bladder cancer	0.00118	0.00121	CcSEcCtD
Pirbuterol—Headache—Methotrexate—urinary bladder cancer	0.00118	0.00121	CcSEcCtD
Pirbuterol—Asthenia—Doxorubicin—urinary bladder cancer	0.00117	0.0012	CcSEcCtD
Pirbuterol—Dizziness—Epirubicin—urinary bladder cancer	0.00116	0.00119	CcSEcCtD
Pirbuterol—Pruritus—Doxorubicin—urinary bladder cancer	0.00115	0.00118	CcSEcCtD
Pirbuterol—Vomiting—Epirubicin—urinary bladder cancer	0.00112	0.00114	CcSEcCtD
Pirbuterol—Nausea—Methotrexate—urinary bladder cancer	0.00111	0.00114	CcSEcCtD
Pirbuterol—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00111	0.00114	CcSEcCtD
Pirbuterol—Rash—Epirubicin—urinary bladder cancer	0.00111	0.00114	CcSEcCtD
Pirbuterol—Dermatitis—Epirubicin—urinary bladder cancer	0.00111	0.00113	CcSEcCtD
Pirbuterol—Headache—Epirubicin—urinary bladder cancer	0.0011	0.00113	CcSEcCtD
Pirbuterol—Dizziness—Doxorubicin—urinary bladder cancer	0.00107	0.0011	CcSEcCtD
Pirbuterol—Nausea—Epirubicin—urinary bladder cancer	0.00104	0.00107	CcSEcCtD
Pirbuterol—Vomiting—Doxorubicin—urinary bladder cancer	0.00103	0.00106	CcSEcCtD
Pirbuterol—Rash—Doxorubicin—urinary bladder cancer	0.00102	0.00105	CcSEcCtD
Pirbuterol—Dermatitis—Doxorubicin—urinary bladder cancer	0.00102	0.00105	CcSEcCtD
Pirbuterol—Headache—Doxorubicin—urinary bladder cancer	0.00102	0.00104	CcSEcCtD
Pirbuterol—Nausea—Doxorubicin—urinary bladder cancer	0.000965	0.00099	CcSEcCtD
